Top Markets
Coin of the day
Biocure Technology Inc. Biocure Technology Inc.

Biocure Technology Inc.

CURE
Pozycja w akcjach #39915
Biocure Technology Inc., operating with its subsidiary, focuses on the creation... Biocure Technology Inc., operating with its subsidiary, focuses on the creation and market introduction of biopharmaceutical innovations, particularly those involving recombinant technologies and ranibizumab. The company's current development pipeline includes: Interferons-ß, aimed at treating multiple sclerosis. Ranibizumab, a monoclonal antibody fragment designed to address macular degeneration and a related eye condition known as macular edema. Filgrastim, which targets neutropenia – a deficiency of white blood cells that can arise from cancer, bone marrow transplants, chemotherapy, or other medical issues. Additionally, Biocure is conducting research and development into several promising areas: CAR T-cell therapy, which works by identifying and eradicating cancer cells. A vaccine against foot and mouth disease. Various products for promoting hair growth. The firm was established in 2005 and its corporate headquarters are located in Vancouver, Canada.
Cena akcji
$0.00366968
Ostatnia synchronizacja: 2024-07-12
Kapitalizacja rynkowa
$299.46K
Zmiana (1 dzień)
-66.77%
Zmiana (1 rok)
0.00%
Kraj
CA
Handel Biocure Technology Inc. (CURE)

Kategoria

Cena CURE z kapitalizacją rynkową B
Biocure Technology Inc. Biocure Technology Inc.
CURE
$0.00366968
Kapitalizacja rynkowa Biocure Technology Inc.(CURE)
Kapitalizacja rynkowa: $299.46K
Na dzień August 2026 spółka Biocure Technology Inc. ma kapitalizację rynkową wynoszącą $299.46K. Według naszych danych, czyni to Biocure Technology Inc. 39915th najcenniejszą firmą na świecie pod względem kapitalizacji rynkowej. Kapitalizacja rynkowa to całkowita wartość rynkowa wszystkich wyemitowanych akcji spółki giełdowej i jest powszechnie stosowana do oceny jej wartości.
Historia kapitalizacji rynkowej Biocure Technology Inc. od 2009 do 2026
CURE w porównaniu do 5 najpopularniejszych stocks
Cena za CURE Aktywa B Kapitalizacja rynkowa B Wyniki
Biocure Technology Inc. Biocure Technology Inc.
$67,025.69 $299.46K
$5.470T +1,826,470,084.21%
Biocure Technology Inc. Biocure Technology Inc.
$54,741.10 $299.46K
$4.467T +1,491,711,392.75%
Biocure Technology Inc. Biocure Technology Inc.
$51,154.44 $299.46K
$4.174T +1,393,973,677.14%
Biocure Technology Inc. Biocure Technology Inc.
$45,342.08 $299.46K
$3.700T +1,235,585,274.74%
Biocure Technology Inc. Biocure Technology Inc.
$34,978.15 $299.46K
$2.854T +953,164,874.40%